يحاول ذهب - حر
Mounjaro as good as older drug on heart-attack risk
August 01, 2025
|Mint Mumbai
A trial of Eli Lilly & Co.'s blockbuster diabetes drug Mounjaro fell short of expectations that it would do a better job of preventing heart attacks and strokes than its older medicine Trulicity.
A head-to-head study of the two treatments—Lilly's largest and longest of Mounjaro to date—was designed to prove what's called non-inferiority, that Mounjaro was an acceptable alternative when it comes to reducing risks from major cardiovascular events compared with Trulicity.
While it achieved that target, the study dashed investors' hopes that Mounjaro would be meaningfully better than its older drug. "There's no mention of superiority, which was also tested for by Lilly," said Bloomberg Intelligence analyst Michael Shah. "So it will likely be received negatively by the market."
Shares in the obesity-drug maker dropped as much as 5.3% in premarket trading in New York. Lilly's shares were down nearly 2% this year as of Wednesday's close, compared with an 8% rise in the S&P 500.
هذه القصة من طبعة August 01, 2025 من Mint Mumbai.
اشترك في Magzter GOLD للوصول إلى آلاف القصص المتميزة المنسقة، وأكثر من 9000 مجلة وصحيفة.
هل أنت مشترك بالفعل؟ تسجيل الدخول
المزيد من القصص من Mint Mumbai
Mint Mumbai
Is New York under Mamdani bent on overtaxing residents?
Expanded city services come at a cost voters may not understand
3 mins
March 02, 2026
Mint Mumbai
IS INSTITUTIONAL INTEGRITY IN INDIA UNDER THREAT?
This is a deep-rooted conspiracy.
3 mins
March 02, 2026
Mint Mumbai
STCG: Does basic exemption limit apply?
I started investing in equities in 2025 and recently sold some shares, booking a small gain.
2 mins
March 02, 2026
Mint Mumbai
Bollywood remains gateway for global music in India
With Bahraini rapper Flipperachi set for an India concert tour after gaining popularity in the country, thanks to his track FAQLA in Aditya Dhar's Dhurandhar, industry experts say Bollywood has, in several cases, acted as a cultural accelerator for international acts in India.
1 mins
March 02, 2026
Mint Mumbai
How Tuhin Kanta Pandey steered Sebi out of crisis
Pandey carried out a steady overhaul of rulebook with active feedback from stakeholders
2 mins
March 02, 2026
Mint Mumbai
'If India starts performing, underweight investors may fuel the rally'
Interest in India is beginning to return among global investors, but the money hasn't followed yet.
3 mins
March 02, 2026
Mint Mumbai
Iran effect: exporters to meet govt today
The commerce ministry has convened a meeting of exporters, shipping lines, freight forwarders and officials from other ministries on Monday to assess the impact of escalating tensions in the Middle East region on India’s trade.
1 min
March 02, 2026
Mint Mumbai
Dorf Ketal to defer IPO plans amid Italmatch bid
Gujarat-based chemicals maker Dorf Ketal Chemicals India Ltd has likely deferred its initial public offering (IPO) as it seeks to raise up to 2,000 crore in a pre-IPO round, two people familiar with the matter said.
1 min
March 02, 2026
Mint Mumbai
THE REAL SCANDAL IN IDFC CASE GOES BEYOND THE FRAUD
The IDFC First Bank fraud has angered people.
2 mins
March 02, 2026
Mint Mumbai
India’s innovation gap shows up in the financial data of our firms
Corporate India must recognize R&D as the foundation of long-term competitiveness before we can hope for breakthroughs
4 mins
March 02, 2026
Listen
Translate
Change font size

